QC
HALO icon

Quadrature Capital’s Halozyme HALO Stock Holding History

Quadrature Capital’s Portfolio HALO Stock Details HALO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.03M Buy
+13,140
New +$896K 0.01% 730
2025
Q3 		– Sell
-26,649
Closed -$1.39M – 1223
2025
Q2 		$1.39M Buy
26,649
+11,662
+78% +$664K 0.02% 365
2025
Q1 		$956K Buy
+14,987
New +$871K 0.02% 443

Other funds holding HALO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Quadrature Capital's HALO Position: Q2 2026 in Review

Quadrature Capital opened a new position in Halozyme (HALO) in Q2 2026: 13,140 shares worth $1.03M. The stake represents 0.01% of the portfolio and ranks #730 among its holdings. This is a return to the name: Quadrature Capital previously reported a position in HALO as recently as Q2 2025.

Quadrature Capital first reported a position in HALO in Q1 2025 and has held it in 3 quarters since. The position peaked at $1.39M in Q2 2025. 674 funds tracked by Wall St. Rank hold HALO as of Q2 2026.

  • Quadrature Capital held 13,140 shares of Halozyme worth $1.03M as of Q2 2026.
  • Halozyme was a new Quadrature Capital position in Q2 2026.
  • Halozyme made up 0.01% of Quadrature Capital's portfolio in Q2 2026, its #730 holding.
  • Quadrature Capital first reported a position in Halozyme in Q1 2025 and has held it in 3 quarters since.
  • Quadrature Capital's Halozyme position peaked at $1.39M in Q2 2025.
  • 674 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.

Based on Quadrature Capital's 13F filing for Q2 2026, filed 7 Aug 2026.